Sigma Pharmaceuticals Ltd
Formerly Arrow Pharmaceuticals Limited, Arrow Pharmaceuticals Pty Ltd
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2009 | $18 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Sigma Pharmaceuticals Ltd had revenue of over $100 million when it filed its newest notice of a funding round (Sep 2009).
SEC Form D (revenue range) · Sep 2009
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Sep 2009
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Sigma Pharmaceuticals Ltd is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 13 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Craig Tomlinson | General Manager Merchandise & Marketing | Sep 2009 |
| Ian Finlay | General Manager Operations | Sep 2009 |
| Jackie Toh | Chief Information Officer and General Manager Wholesaling | Sep 2009 |
| James Barrie | Commercial Finance and Investor Relations Manager | Sep 2009 |
| Keith Jeffs | General Manager Orphan Australia | Sep 2009 |
| Mark Smith | Chief Financial Officer | Sep 2009 |
| Michael Long | General Manager Export and Contracts | Sep 2009 |
| Peter Tilley | General Manager Retail Operations | Sep 2009 |
| Robert Ellis | General Manager Business Development | Sep 2009 |
| Steve Waller | General Manager - Consumer and Medical | Sep 2009 |
| Sue Morgan Dethick | General Counsel and Company Secretary | Sep 2009 |
| Brian Jamieson | Director | Sep 2009 |
| David S Bayes | Director | Sep 2009 |
| Elmo de Alwis | Managing Director | Sep 2009 |
| Geoffrey D W Curlewis | Director | Sep 2009 |
| John W Stocker AO | Chairman | Sep 2009 |
| Linda B Nicholls | Director | Sep 2009 |
| William J Scott | Director | Sep 2009 |